Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus-Reference-Cited by-同舟云学术

Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus

Published:2013-10-17 Issue:12 Volume:83 Page:1096-1104
ISSN:1552-4922
Container-title:Cytometry Part A
language:en
Short-container-title:Cytometry

Author:

Maguire Orla¹,Tornatore Kathleen M.²³,O'Loughlin Kieran L.¹,Venuto Rocco C.³,Minderman Hans¹

Affiliation:

1. Department of Flow and Image Cytometry; Roswell Park Cancer Institute, University at Buffalo; New York

2. Immunosuppressive Pharmacology Research Program, Translational Pharmacology Research Center; NYS Center of Excellence in Bioinformatics and Life Sciences, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo; New York

3. Division of Nephrology, Department of Medicine; Erie County Medical Center, School of Medicine and Biomedical Sciences; University at Buffalo; Buffalo New York

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference40 articles.

1. Immunosuppressive drugs for kidney transplantation;Halloran;N Engl J Med,2004

2. NFAT pulls the strings during CD4+ T helper cell effector functions;Hermann-Kleiter;Blood,2010

3. Organ transplantation-How much of the promise has been realized?;Lechler;Nat Med,2005

4. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation;Staatz;Clin Pharmacokinet,2004

5. NFAT proteins: Emerging roles in cancer progression;Mancini;Nat Rev Cancer,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-modal immune dynamics of pre-COVID-19 Kawasaki Disease following intravenous immunoglobulin;Clinical Immunology;2024-10

2. Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment;EMBO Molecular Medicine;2024-07-26

3. Shifting phenotype and differentiation of CD11b+Gr.1+ immature heterogeneous myeloid derived adjuster cells support inflammation and induce regulators of IL17A in imiquimod induced psoriasis;Inflammation Research;2024-07-25

4. Effect of rituximab in patients with PLA2R-associated membranous nephropathy and malignancy;International Immunopharmacology;2024-01

5. Elucidation of GPR55-Associated Signaling behind THC and LPI Reducing Effects on Ki67-Immunoreactive Nuclei in Patient-Derived Glioblastoma Cells;Cells;2023-11-17